EVALUATING HEMATOLOGICAL AND INFLAMMATORY BIOMARKERS IN TUBERCULOSIS MANAGEMENT. rjnmsr [Internet]. 2026 May 14 [cited 2026 May 14];4(5):249-58. Available from: https://nmsreview.org/index.php/rjnmsr/article/view/890